FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019845 [Registered on: 25/06/2019] Trial Registered Prospectively
Last Modified On: 17/11/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the beneficial effects of the drug Rupatadine in Low Back Pain 
Scientific Title of Study   Efficacy and safety of add-on Rupatadine treatment for Chronic low back pain- An assessor blind randomized controlled clinical study-A pilot study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR V Sathyanarayanan 
Designation  Professor of Pharmacology 
Affiliation  SRM Medical College SRM IST 
Address  SRM Medical College Hospital and Research Centre SRM IST SRM Nagar Potheri Kattankulathur post Kanchipuram district

Kancheepuram
TAMIL NADU
603203
India 
Phone  919384633405  
Fax    
Email  satya672000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Heena Goldin B 
Designation  Post Graduate 
Affiliation  SRM Medical College SRM IST 
Address  SRM Medical College Hospital and Research Centre SRM IST SRM Nagar Potheri Kattankulathur post Kanchipuram district

Kancheepuram
TAMIL NADU
603203
India 
Phone  9176468465  
Fax    
Email  heenagoldin8@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Heena Goldin B 
Designation  Post Graduate 
Affiliation  SRM Medical College SRM IST 
Address  SRM Medical College Hospital and Research Centre SRM IST SRM Nagar Potheri Kattankulathur post Kanchipuram district

Kancheepuram
TAMIL NADU
603203
India 
Phone  9176468465  
Fax    
Email  heenagoldin8@gmail.com  
 
Source of Monetary or Material Support  
SRM Medical College Hospital and Research Centre SRM IST Potheri Kattankulathur post Kancheepuram district Tamilnadu Pincode 603203 
 
Primary Sponsor  
Name  SRM Institute of Science and Technology 
Address  SRM Nagar Potheri Kattankulathur Post Kancheepuram district Tamilnadu 603203 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Heena Goldin B  SRM Hospital   Outpatient Department Department of Orthopaedics SRM Nagar Potheri Kattankulathur Post Kancheepuram district Tamilnadu 603203 India
Kancheepuram
TAMIL NADU 
9176468465

heenagoldin8@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M791||Myalgia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Aceclofenac CR   Aceclofenac CR 200 mg once daily for two months 
Intervention  Rupatadine and Aceclofenac CR  Rupatadine 10 mg once daily and Aceclofenac CR 200 mg once daily for two months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Age group 18-60 years
2. Subjects with Chronic Low Back Pain more than three months, Visual analog scale more than 40 mm
3. Both genders
4. Patients willing to give consent
 
 
ExclusionCriteria 
Details  1. History of acute fracture
2. History of malignancy or neurological deficit or severe leg pain mandating surgery
3. History of lumbar disc herniation or spinal stenosis
4. History of fibromyalgia or spinal surgery
5. History of recent trauma or injury
6. History of alcohol or narcotic abuse
7. History of Peptic ulcer disease or hepatic and renal dysfunction
8. History of heart surgery
9. History of Allergy to Aceclofenac CR or H1 antagonists
10. Pregnant,lactating women
11. Psychiatric disorders
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Pain relief to be assessed   at the baseline, at second week, at the end of each month for two months using Visual Analog Pain Score 
 
Secondary Outcome  
Outcome  TimePoints 
Disability and Quality of Life to be assessed by Oswestry Disability Index questionnaire,WHOQOLBREF questionnaire respectively   at the baseline and at the end of the each month for two months 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/07/2019 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
PRIMARY PURPOSE OF THE PROTOCOL:

Aim of the study: To determine the efficacy and safety of Rupatadine and Aceclofenac CR in comparison with Aceclofenac CR alone in treatment of Chronic low back pain

Objectives of the study:

1. To evaluate whether Rupatadine and Aceclofenac CR provide better pain relief in comparison with Aceclofenac CR alone in Chronic low back pain assessed by using Visual Analog Pain score

2.To evaluate whether Rupatadine and Aceclofenac CR decreases disability in comparison with Aceclofenac CR alone in Chronic low back pain assessed by using Oswestry disability index questionnaire

3.To evaluate whether Rupatadine and Aceclofenac CR improves the quality of life in Chronic low back pain in comparison with Aceclofenac CR alone assessed by using WHOQOL BREF questionnaire

Hypothesis :

Rupatadine and Aceclofenac CR may be more efficacious when compared to Aceclofenac CR alone in the treatment of Chronic low back pain
 
Close